Clinical Trial: A Prospective, Open-Label, Exploratory Clinical Study of Adebrelimab Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Immune Checkpoint Inhibitors (China)

Posted On: 2026-08-26

China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Open-Label, Exploratory Clinical Study of Adebrelimab Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Immune Checkpoint Inhibitors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130857

Registration Time: 2026/08/25

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338211

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective, Open-Label, Exploratory Clinical Study of Adebrelimab Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Immune Checkpoint Inhibitors (China)